AKT1 and neoplasm: In many cell lines, especially tumor cell lines, AKT function is inhibited primarily by inhibiting PI3K function, such as by treatment with specific inhibitors of PI3K, such as LY294002 and Wortmannin, as indicated by reduced p-AKT (Ser473) expression.